Mr. Shengjun, who is the member of the Chinese Communist Party, is a Professor and Doctor of molecular chemistry and molecular biology.
In 1986, Mr.Shengjun was graduated from Animal Department of Northeast Forest College and passed the entrance examination of CCIBP for Medicine Immunology Master's degree. As a postgraduate, he took part in the research of the pilot process of recombinant hepatitis B vaccine, which was one of the 863 Plans in China, and established the detecting method of residual DNA of recombinant hepatitis B. In 1989,he got Master's degree of the Medicine Immunology and worked in CCIBP for further research.
In 1990,Mr. Shengjun left for Osaka in Japan for the Doctor' Degree of Biochemistry & Molecular Biology. During the time in Japan, he got the Assistant Award from Osaka Microbiological Institute and the scholarship from the Ministry of Education of Japan. He is the first man in the world who states the molecular mechanism. He also established the Association of Molecular Biology for the people studied in Japan and he was the first chairman of the Association. He published the Digest Newspaper of the students in Japan. He also came back home several times to give lectures, which were sponsored by Chinese Natural Scientific Foundation. He had taken part in the 2nd Youth Academic Annual Conference of Scientific Association of China and was interviewed by the President Jiang Ze-min
In 1996, Mr. Shengjun returned Changchun Institute of Biological Products and was assigned as the director of the molecular biology research department. In this period, he undertook several important scientific research projects, such as 863 Plan, the Ninth Five-Year Plan, the Special Project Foundation for Excellent Youth of Ministry of Public Health and the Start-up Foundation for Returned Scholars, etc.. He and his colleagues also manufactured several high-tech products, such as Interferon Ointment, Recombinant Interferon ¦Á-2b Injection, etc..
In 1998, Mr. Sheng acceded in Changchun Medicine Group and was assigned as the vice president and was in charge of the development of the technology and market. At the same time, he hold the following concurrent posts, Director of Changchun High-tech Property (Group) Co., Chairman Director and General Manager of the Research and Development Company for New Medicine of Changchun Medicine Group, Chairman Director and Vice Headmaster of Changchun Medicine Group College of Norman Bethune University of Medical Sciences and as a Director of the students for the Doctor' Degree , Director of the students for the Master's Degree in Academy of Anima Sciences of Jilin University. During this time, he invented Recombinant Human Interferon (in liquid), got the Excellent Youth Award of Jilin Province.
In 2001, he was appointed as the president (legal representative) and the secretary of the Chinese Communist Party Committee of Changchun Institute of Biological Products. Mr. Shengjun has issued over ten valuable theses both home and abroad. He is one of the few returned Doctors in bio-pharm area and has also successfully held the following posts: a member of new drug evaluation committee of State Drug Administration, managing vice editor of Chinese Journal of Biologicals, vice board chairman of Jilin Genetic Association, member of standing committee of Biological Association under China Preventive Medical Association, member of expert committee of the tenth five-year national high-tech research and development plan.
WASHINGTON -- In 1991, when Bill Clinton let on he was running for the White House, Arkansas fund-raiser Yah Lin "Charlie" Trie tried to develop a sister city relationship between Little Rock and Changchun, China -- a key biowarfare research hub, sources say.
While visiting the Chinese city, where he eventually bought a home, Trie brokered deals to export biotech equipment to a Changchun lab suspected of being a Chinese army front for the manufacture of agents used in biological weapons. Changchun is in Jilin province, which borders North Korea. It's also near Harbin, China's new propaganda center for biowarfare.
"During one of his early visits to Changchun, Trie met with Zhang Jianming, director of the Changchun Biological Products Institute," according to a copy of FBI summaries of interviews with Trie obtained by WorldNetDaily. The lab, a unit of the Public Health Ministry, is run by the Chinese communist government.
The news of a major Clinton donor transferring dual-use biotechnology to China comes as Beijing is "investing huge resources" in its biological warfare program, a source in China told WND.
Long-time Clinton friend Yah Lin "Charlie" Trie Trie, convicted last year of breaking campaign-finance laws, was given no jail time in exchange for his cooperation in an ongoing investigation by the Justice Department's campaign-finance task force.
In 1996, he gave close to $1 million to the Clinton-Gore reelection effort and Clinton's Legal Expense Trust. His money had to be returned. Some gifts were laundered through Chinese sources, the FBI report shows. Justice has agreed to let Trie testify under a grant of immunity before the House Government Reform Committee. He's scheduled to appear Wednesday and Thursday.
Trie formed a close bond with the bio lab chief while in Changchun, where Trie and his late wife bought a home for $20,000.
"Trie provided a letter of invitation for Zhang to use in obtaining a visa to the United States," the 150-page FBI reports says. "Once in the United States, Trie accompanied Zhang on his travels."
Zhang visited Little Rock and, in November 1992 -- after Clinton was elected president -- he and Trie set up what appears to be a shell company called United Biotech. The company had a bank account and a Little Rock address, but no business pl
an or real income. The firm was dissolved a year later.
But in that time, Trie helped Zhang procure a 132-gallon "medical fermentation tank" from a New York-based manufacturer, according to the FBI. "He got them the fermenting equipment to grow the bugs" used in germ warfare, a senior Pentagon official told WorldNetDaily. Special agents worry that the Chinese government may have used the apparent shell company to acquire other biotech equipment.
"Trie was asked if he thought it possible, considering the high priority the People's Republic of China gave to acquiring advanced biotechnology, that the United Biotech corporate name and address may have been used by PRC purchasing agents to make purchases (from manufacturers) elsewhere in the U.S.," FBI agents said in the report. Though Trie denies that happened, United Biotech isn't the only trading company he has set up.
A search of Arkansas secretary of state records for DBAs, sole proprietorships and incorporations registered under Trie's name turns up no less than six import-export or international consulting businesses. They include Jesco International Inc., Asian Pacific International Inc., Daihatsu International Trading Inc., Premier International Investment Inc. and T&L International Inc. At least one, Jesco International, traded with China before going out of business.
According to the FBI report, the 50-year-old Trie had an ethnic-Chinese "silent partner" -- Dr. Peter P. Fu -- who invested in Daihatsu International. An FDA toxicologist, Fu met Chinese scientist Zhang in Little Rock after Clinton was elected. Fu works for the National Center for Toxicological Research in Jefferson, Ark., which is about halfway between Little Rock and Pine Bluff, Ark.
The federal lab, on a 496-acre campus, conducts experiments in biochemical toxicology, genetic toxicology, neurotoxicology, microbiology and molecular epidemiology, its website says. Some pathology labs do studies of "microorganisms multiplying and producing infections." The center has an active lab-to-lab scientific exchange program with a medical institution in China. And in 1993, it hosted an "international group of inspectors interested in Biological Weapons Treaty issues."
Trie told FBI agents he didn't think Fu, 58, had any ties to Beijing. At that, agents produced one of Fu's business cards "indicating that Dr. Fu has ties with two institutions managed by the PRC government." The biotech equipment transfer opens up a new and dangerous front in the mushrooming Chinagate scandal, in which China's People's Liberation Army spies conspired with Clinton-Gore bagmen to illegally sway the election and influence White House trade and military policy. The PLA is frantically trying to modernize its weapons systems, and needs U.S. military technology to do it.
Despite the Clinton administration's portrayal of China as a benign "strategic partner," Beijing has targeted Taiwan -- and its military ally by law, the U.S. -- for missile attack. It's also threatening information warfare, or IW, such as hacking into U.S. computers to create chaos and shorting communications with electronic pulses.
A former Brookings Institution defense analyst who's now a consultant in Beijing warns that Americans are worrying about the wrong kind of unconventional warfare. Biowarfare, not IW, is the real threat, he says. "Americans have focused on the computer virus attack stuff because that's particularly interesting to us, but the Chinese have actually invested huge resources into uninhibited biotech," the Beijing source said. "They may be picking up some Soviet research into biowarfare as well."
He added that the PLA, through its front companies, is interested in acquiring U.S. biotech equipment for use in "precisely this area." In Harbin, just North of Changchun in Manchuria, the Chinese government has erected a museum on the former grounds of a Japanese biowarfare testing center that used Chinese as subjects during WWII, the source says. The museum is an important propaganda mill for the new Beijing line that the U.S. used biological weapons against the Chinese during the Korean War.
Even though China joined the Biological Weapons Convention in 1984, it has violated the pact and maintained an offensive germ-warfare program, according to a 1997 report by the Arms Control and Disarmament Agency. That year, Secretary of State Madeleine Albright had to concede to the Senate Foreign Relations Committee that classified reports show Chinese firms have shipped biowarfare equipment to Iran.
Clinton has maintained for years that biowarfare is a top national security concern. "We've got to continue to meet the new security challenges of the 21st century, especially the challenges of terrorism and biological and chemical weapons," he said Feb. 8.